nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—HRH1—atherosclerosis	0.724	1	CbGaD
Orphenadrine—CYP2B6—Simvastatin—atherosclerosis	0.0545	0.389	CbGbCtD
Orphenadrine—CYP3A4—Ezetimibe—atherosclerosis	0.018	0.129	CbGbCtD
Orphenadrine—CYP3A4—Rosuvastatin—atherosclerosis	0.018	0.129	CbGbCtD
Orphenadrine—CYP3A4—Simvastatin—atherosclerosis	0.0168	0.12	CbGbCtD
Orphenadrine—CYP3A4—Pravastatin—atherosclerosis	0.0164	0.117	CbGbCtD
Orphenadrine—CYP3A4—Lovastatin—atherosclerosis	0.0164	0.117	CbGbCtD
Orphenadrine—Confusional state—Rosuvastatin—atherosclerosis	0.00107	0.0187	CcSEcCtD
Orphenadrine—Vision blurred—Lovastatin—atherosclerosis	0.00104	0.0181	CcSEcCtD
Orphenadrine—Tremor—Lovastatin—atherosclerosis	0.00103	0.018	CcSEcCtD
Orphenadrine—Vision blurred—Simvastatin—atherosclerosis	0.000972	0.0169	CcSEcCtD
Orphenadrine—Tremor—Simvastatin—atherosclerosis	0.000966	0.0168	CcSEcCtD
Orphenadrine—Palpitations—Ezetimibe—atherosclerosis	0.000956	0.0167	CcSEcCtD
Orphenadrine—Tension—Niacin—atherosclerosis	0.000929	0.0162	CcSEcCtD
Orphenadrine—Tension—Pravastatin—atherosclerosis	0.000915	0.016	CcSEcCtD
Orphenadrine—Constipation—Rosuvastatin—atherosclerosis	0.000908	0.0158	CcSEcCtD
Orphenadrine—Confusional state—Lovastatin—atherosclerosis	0.000907	0.0158	CcSEcCtD
Orphenadrine—Anaphylactic shock—Lovastatin—atherosclerosis	0.0009	0.0157	CcSEcCtD
Orphenadrine—Vision blurred—Niacin—atherosclerosis	0.000892	0.0156	CcSEcCtD
Orphenadrine—Confusional state—Ezetimibe—atherosclerosis	0.00089	0.0155	CcSEcCtD
Orphenadrine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000883	0.0154	CcSEcCtD
Orphenadrine—Vision blurred—Pravastatin—atherosclerosis	0.000879	0.0153	CcSEcCtD
Orphenadrine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000875	0.0153	CcSEcCtD
Orphenadrine—Tremor—Pravastatin—atherosclerosis	0.000874	0.0152	CcSEcCtD
Orphenadrine—Skin disorder—Ezetimibe—atherosclerosis	0.000857	0.0149	CcSEcCtD
Orphenadrine—Confusional state—Simvastatin—atherosclerosis	0.000849	0.0148	CcSEcCtD
Orphenadrine—Urticaria—Rosuvastatin—atherosclerosis	0.000844	0.0147	CcSEcCtD
Orphenadrine—Anaphylactic shock—Simvastatin—atherosclerosis	0.000842	0.0147	CcSEcCtD
Orphenadrine—Palpitations—Niacin—atherosclerosis	0.000837	0.0146	CcSEcCtD
Orphenadrine—Dimenhydrinate—HRH1—atherosclerosis	0.000805	0.0844	CrCbGaD
Orphenadrine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000782	0.0136	CcSEcCtD
Orphenadrine—Anaphylactic shock—Niacin—atherosclerosis	0.000773	0.0135	CcSEcCtD
Orphenadrine—Constipation—Lovastatin—atherosclerosis	0.00077	0.0134	CcSEcCtD
Orphenadrine—Confusional state—Pravastatin—atherosclerosis	0.000767	0.0134	CcSEcCtD
Orphenadrine—Asthenia—Rosuvastatin—atherosclerosis	0.000762	0.0133	CcSEcCtD
Orphenadrine—Anaphylactic shock—Pravastatin—atherosclerosis	0.000761	0.0133	CcSEcCtD
Orphenadrine—Constipation—Ezetimibe—atherosclerosis	0.000755	0.0132	CcSEcCtD
Orphenadrine—Tachycardia—Niacin—atherosclerosis	0.000754	0.0132	CcSEcCtD
Orphenadrine—Pruritus—Rosuvastatin—atherosclerosis	0.000751	0.0131	CcSEcCtD
Orphenadrine—Skin disorder—Niacin—atherosclerosis	0.000751	0.0131	CcSEcCtD
Orphenadrine—Feeling abnormal—Lovastatin—atherosclerosis	0.000742	0.0129	CcSEcCtD
Orphenadrine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000727	0.0127	CcSEcCtD
Orphenadrine—Constipation—Simvastatin—atherosclerosis	0.00072	0.0126	CcSEcCtD
Orphenadrine—Urticaria—Lovastatin—atherosclerosis	0.000715	0.0125	CcSEcCtD
Orphenadrine—Dizziness—Rosuvastatin—atherosclerosis	0.000702	0.0122	CcSEcCtD
Orphenadrine—Urticaria—Ezetimibe—atherosclerosis	0.000701	0.0122	CcSEcCtD
Orphenadrine—Feeling abnormal—Simvastatin—atherosclerosis	0.000694	0.0121	CcSEcCtD
Orphenadrine—Somnolence—Niacin—atherosclerosis	0.000687	0.012	CcSEcCtD
Orphenadrine—Urticaria—Simvastatin—atherosclerosis	0.000669	0.0117	CcSEcCtD
Orphenadrine—Headache—Rosuvastatin—atherosclerosis	0.000665	0.0116	CcSEcCtD
Orphenadrine—Hypersensitivity—Lovastatin—atherosclerosis	0.000663	0.0116	CcSEcCtD
Orphenadrine—Constipation—Pravastatin—atherosclerosis	0.000651	0.0113	CcSEcCtD
Orphenadrine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00065	0.0113	CcSEcCtD
Orphenadrine—Asthenia—Lovastatin—atherosclerosis	0.000646	0.0113	CcSEcCtD
Orphenadrine—Pruritus—Lovastatin—atherosclerosis	0.000637	0.0111	CcSEcCtD
Orphenadrine—Asthenia—Ezetimibe—atherosclerosis	0.000633	0.011	CcSEcCtD
Orphenadrine—Nausea—Rosuvastatin—atherosclerosis	0.000631	0.011	CcSEcCtD
Orphenadrine—Feeling abnormal—Pravastatin—atherosclerosis	0.000627	0.0109	CcSEcCtD
Orphenadrine—Pruritus—Ezetimibe—atherosclerosis	0.000624	0.0109	CcSEcCtD
Orphenadrine—Hypersensitivity—Simvastatin—atherosclerosis	0.00062	0.0108	CcSEcCtD
Orphenadrine—Urticaria—Niacin—atherosclerosis	0.000614	0.0107	CcSEcCtD
Orphenadrine—Dexbrompheniramine—HRH1—atherosclerosis	0.00061	0.064	CrCbGaD
Orphenadrine—Urticaria—Pravastatin—atherosclerosis	0.000605	0.0105	CcSEcCtD
Orphenadrine—Asthenia—Simvastatin—atherosclerosis	0.000604	0.0105	CcSEcCtD
Orphenadrine—Pheniramine—HRH1—atherosclerosis	0.000597	0.0626	CrCbGaD
Orphenadrine—Pruritus—Simvastatin—atherosclerosis	0.000596	0.0104	CcSEcCtD
Orphenadrine—Dizziness—Lovastatin—atherosclerosis	0.000595	0.0104	CcSEcCtD
Orphenadrine—Dizziness—Ezetimibe—atherosclerosis	0.000584	0.0102	CcSEcCtD
Orphenadrine—Vomiting—Lovastatin—atherosclerosis	0.000572	0.00998	CcSEcCtD
Orphenadrine—Hypersensitivity—Niacin—atherosclerosis	0.000569	0.00993	CcSEcCtD
Orphenadrine—Headache—Lovastatin—atherosclerosis	0.000564	0.00983	CcSEcCtD
Orphenadrine—Vomiting—Ezetimibe—atherosclerosis	0.000561	0.00979	CcSEcCtD
Orphenadrine—Hypersensitivity—Pravastatin—atherosclerosis	0.000561	0.00978	CcSEcCtD
Orphenadrine—Dizziness—Simvastatin—atherosclerosis	0.000557	0.00971	CcSEcCtD
Orphenadrine—Asthenia—Niacin—atherosclerosis	0.000555	0.00967	CcSEcCtD
Orphenadrine—Headache—Ezetimibe—atherosclerosis	0.000553	0.00964	CcSEcCtD
Orphenadrine—Pruritus—Niacin—atherosclerosis	0.000547	0.00953	CcSEcCtD
Orphenadrine—Asthenia—Pravastatin—atherosclerosis	0.000546	0.00952	CcSEcCtD
Orphenadrine—Clofedanol—HRH1—atherosclerosis	0.000544	0.057	CrCbGaD
Orphenadrine—Pruritus—Pravastatin—atherosclerosis	0.000538	0.00939	CcSEcCtD
Orphenadrine—Vomiting—Simvastatin—atherosclerosis	0.000535	0.00933	CcSEcCtD
Orphenadrine—Nausea—Lovastatin—atherosclerosis	0.000535	0.00932	CcSEcCtD
Orphenadrine—Headache—Simvastatin—atherosclerosis	0.000527	0.00919	CcSEcCtD
Orphenadrine—Nausea—Ezetimibe—atherosclerosis	0.000524	0.00914	CcSEcCtD
Orphenadrine—Mepyramine—HRH1—atherosclerosis	0.000511	0.0536	CrCbGaD
Orphenadrine—Dizziness—Niacin—atherosclerosis	0.000511	0.00891	CcSEcCtD
Orphenadrine—Dizziness—Pravastatin—atherosclerosis	0.000503	0.00877	CcSEcCtD
Orphenadrine—Nausea—Simvastatin—atherosclerosis	0.0005	0.00872	CcSEcCtD
Orphenadrine—Doxylamine—HRH1—atherosclerosis	0.000497	0.0522	CrCbGaD
Orphenadrine—Vomiting—Niacin—atherosclerosis	0.000491	0.00857	CcSEcCtD
Orphenadrine—Headache—Niacin—atherosclerosis	0.000484	0.00844	CcSEcCtD
Orphenadrine—Vomiting—Pravastatin—atherosclerosis	0.000484	0.00844	CcSEcCtD
Orphenadrine—Headache—Pravastatin—atherosclerosis	0.000477	0.00831	CcSEcCtD
Orphenadrine—Diphenylpyraline—HRH1—atherosclerosis	0.000473	0.0496	CrCbGaD
Orphenadrine—Tripelennamine—HRH1—atherosclerosis	0.000473	0.0496	CrCbGaD
Orphenadrine—Nausea—Niacin—atherosclerosis	0.000459	0.00801	CcSEcCtD
Orphenadrine—Nausea—Pravastatin—atherosclerosis	0.000452	0.00788	CcSEcCtD
Orphenadrine—Dimetindene—HRH1—atherosclerosis	0.000435	0.0456	CrCbGaD
Orphenadrine—Alimemazine—HRH1—atherosclerosis	0.000427	0.0447	CrCbGaD
Orphenadrine—Bromodiphenhydramine—HRH1—atherosclerosis	0.000389	0.0408	CrCbGaD
Orphenadrine—Cyclizine—HRH1—atherosclerosis	0.000381	0.0399	CrCbGaD
Orphenadrine—Benzatropine—HRH1—atherosclerosis	0.000363	0.038	CrCbGaD
Orphenadrine—Carbinoxamine—HRH1—atherosclerosis	0.000323	0.0339	CrCbGaD
Orphenadrine—Brompheniramine—HRH1—atherosclerosis	0.00028	0.0294	CrCbGaD
Orphenadrine—Chlorphenamine—HRH1—atherosclerosis	0.000275	0.0288	CrCbGaD
Orphenadrine—Toremifene—ESR1—atherosclerosis	0.000236	0.0247	CrCbGaD
Orphenadrine—Trimipramine—HRH1—atherosclerosis	0.00019	0.0199	CrCbGaD
Orphenadrine—Diphenhydramine—HRH1—atherosclerosis	0.000187	0.0196	CrCbGaD
Orphenadrine—Promethazine—HRH1—atherosclerosis	0.000183	0.0192	CrCbGaD
Orphenadrine—Doxepin—HRH1—atherosclerosis	0.000181	0.019	CrCbGaD
Orphenadrine—Promazine—HRH1—atherosclerosis	0.000161	0.0169	CrCbGaD
Orphenadrine—Tamoxifen—ESR2—atherosclerosis	0.000153	0.016	CrCbGaD
Orphenadrine—Imipramine—HRH1—atherosclerosis	0.000141	0.0148	CrCbGaD
Orphenadrine—Amitriptyline—HRH1—atherosclerosis	0.00014	0.0147	CrCbGaD
Orphenadrine—Fenoprofen—PTGS2—atherosclerosis	0.000111	0.0116	CrCbGaD
Orphenadrine—Fenoprofen—ALB—atherosclerosis	9.9e-05	0.0104	CrCbGaD
Orphenadrine—Tamoxifen—ESR1—atherosclerosis	9.42e-05	0.00988	CrCbGaD
Orphenadrine—Phenprocoumon—ALB—atherosclerosis	8.53e-05	0.00895	CrCbGaD
Orphenadrine—Fluoxetine—ALB—atherosclerosis	8.3e-05	0.00871	CrCbGaD
Orphenadrine—Warfarin—ALB—atherosclerosis	7.57e-05	0.00794	CrCbGaD
Orphenadrine—Amitriptyline—ALB—atherosclerosis	3.23e-05	0.00339	CrCbGaD
Orphenadrine—CYP2B6—Metabolism—PLA2G1B—atherosclerosis	1.78e-05	0.000258	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CX3CR1—atherosclerosis	1.78e-05	0.000258	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASR—atherosclerosis	1.78e-05	0.000258	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CX3CL1—atherosclerosis	1.77e-05	0.000257	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—AKT1—atherosclerosis	1.76e-05	0.000256	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—EDN1—atherosclerosis	1.76e-05	0.000255	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CX3CL1—atherosclerosis	1.75e-05	0.000253	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CCL5—atherosclerosis	1.74e-05	0.000253	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PLA2G1B—atherosclerosis	1.74e-05	0.000253	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	1.73e-05	0.000251	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALOX5—atherosclerosis	1.72e-05	0.000249	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	1.72e-05	0.000249	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLTP—atherosclerosis	1.69e-05	0.000245	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALOX5—atherosclerosis	1.68e-05	0.000244	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CNR2—atherosclerosis	1.68e-05	0.000244	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CXCL8—atherosclerosis	1.68e-05	0.000244	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MMP3—atherosclerosis	1.68e-05	0.000243	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	1.67e-05	0.000243	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PRKCG—atherosclerosis	1.66e-05	0.00024	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CNR2—atherosclerosis	1.65e-05	0.00024	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	1.65e-05	0.00024	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	1.65e-05	0.000239	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—IL6—atherosclerosis	1.64e-05	0.000238	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	1.63e-05	0.000236	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—EDN1—atherosclerosis	1.6e-05	0.000231	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL5—atherosclerosis	1.58e-05	0.00023	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	1.57e-05	0.000228	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	1.56e-05	0.000226	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NAMPT—atherosclerosis	1.54e-05	0.000224	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—LIPC—atherosclerosis	1.53e-05	0.000222	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOC3—atherosclerosis	1.52e-05	0.000221	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—AKT1—atherosclerosis	1.51e-05	0.00022	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—LDLR—atherosclerosis	1.51e-05	0.000219	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NAMPT—atherosclerosis	1.51e-05	0.000219	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PRKCG—atherosclerosis	1.51e-05	0.000218	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—LIPC—atherosclerosis	1.5e-05	0.000218	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VWF—atherosclerosis	1.5e-05	0.000217	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOC3—atherosclerosis	1.49e-05	0.000216	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOC3—atherosclerosis	1.49e-05	0.000216	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—LDLR—atherosclerosis	1.48e-05	0.000215	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	1.48e-05	0.000215	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LDLR—atherosclerosis	1.48e-05	0.000215	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CETP—atherosclerosis	1.48e-05	0.000214	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VWF—atherosclerosis	1.47e-05	0.000214	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOC3—atherosclerosis	1.47e-05	0.000212	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.46e-05	0.000212	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.46e-05	0.000212	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AGT—atherosclerosis	1.46e-05	0.000211	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LDLR—atherosclerosis	1.46e-05	0.000211	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CETP—atherosclerosis	1.45e-05	0.00021	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL3—atherosclerosis	1.45e-05	0.00021	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	1.44e-05	0.000208	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL3—atherosclerosis	1.42e-05	0.000206	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SCARB1—atherosclerosis	1.42e-05	0.000205	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SCARB1—atherosclerosis	1.39e-05	0.000201	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NCF1—atherosclerosis	1.38e-05	0.000201	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NCF1—atherosclerosis	1.36e-05	0.000198	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—F2—atherosclerosis	1.35e-05	0.000195	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HMGCR—atherosclerosis	1.34e-05	0.000194	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—F2—atherosclerosis	1.33e-05	0.000192	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AGT—atherosclerosis	1.32e-05	0.000192	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HMGCR—atherosclerosis	1.31e-05	0.00019	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCR2—atherosclerosis	1.31e-05	0.00019	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EDNRA—atherosclerosis	1.31e-05	0.00019	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AGT—atherosclerosis	1.3e-05	0.000189	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CYBA—atherosclerosis	1.3e-05	0.000189	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CG—atherosclerosis	1.29e-05	0.000187	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	1.29e-05	0.000187	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCR2—atherosclerosis	1.29e-05	0.000187	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CYBA—atherosclerosis	1.28e-05	0.000186	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLAT—atherosclerosis	1.27e-05	0.000185	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PARP1—atherosclerosis	1.27e-05	0.000185	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GHRL—atherosclerosis	1.27e-05	0.000185	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	1.27e-05	0.000184	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLAT—atherosclerosis	1.25e-05	0.000182	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PARP1—atherosclerosis	1.25e-05	0.000182	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GHRL—atherosclerosis	1.25e-05	0.000182	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—F2—atherosclerosis	1.22e-05	0.000177	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—F2—atherosclerosis	1.2e-05	0.000175	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCA1—atherosclerosis	1.19e-05	0.000173	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CG—atherosclerosis	1.17e-05	0.00017	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCA1—atherosclerosis	1.17e-05	0.000169	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.16e-05	0.000168	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	1.15e-05	0.000167	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KNG1—atherosclerosis	1.12e-05	0.000162	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AGTR1—atherosclerosis	1.11e-05	0.000161	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	1.1e-05	0.00016	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	1.09e-05	0.000159	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CCL2—atherosclerosis	1.09e-05	0.000158	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LCAT—atherosclerosis	1.09e-05	0.000158	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—FABP4—atherosclerosis	1.09e-05	0.000158	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PLG—atherosclerosis	1.08e-05	0.000157	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	1.07e-05	0.000156	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA4—atherosclerosis	1.07e-05	0.000155	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PLG—atherosclerosis	1.07e-05	0.000155	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.05e-05	0.000152	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SOCS3—atherosclerosis	1.03e-05	0.000149	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—HMOX1—atherosclerosis	1.02e-05	0.000148	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	1.01e-05	0.000146	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—HMOX1—atherosclerosis	1e-05	0.000145	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP3—atherosclerosis	9.91e-06	0.000144	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF2—atherosclerosis	9.87e-06	0.000143	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOB—atherosclerosis	9.79e-06	0.000142	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	9.75e-06	0.000141	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	9.71e-06	0.000141	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.69e-06	0.000141	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOB—atherosclerosis	9.59e-06	0.000139	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOB—atherosclerosis	9.58e-06	0.000139	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—atherosclerosis	9.52e-06	0.000138	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	9.5e-06	0.000138	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EDN1—atherosclerosis	9.43e-06	0.000137	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOB—atherosclerosis	9.42e-06	0.000137	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL5—atherosclerosis	9.35e-06	0.000136	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—LPL—atherosclerosis	9.35e-06	0.000136	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	9.34e-06	0.000135	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—atherosclerosis	9.33e-06	0.000135	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	9.27e-06	0.000134	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	9.2e-06	0.000133	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA2—atherosclerosis	9.19e-06	0.000133	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	9.19e-06	0.000133	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALOX15—atherosclerosis	9.19e-06	0.000133	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	9.19e-06	0.000133	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—LPL—atherosclerosis	9.16e-06	0.000133	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LPL—atherosclerosis	9.15e-06	0.000133	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPX1—atherosclerosis	9.12e-06	0.000132	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCG5—atherosclerosis	9.07e-06	0.000132	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LPL—atherosclerosis	9e-06	0.00013	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPX1—atherosclerosis	8.93e-06	0.00013	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PRKCG—atherosclerosis	8.89e-06	0.000129	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CD36—atherosclerosis	8.88e-06	0.000129	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LPA—atherosclerosis	8.76e-06	0.000127	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	8.75e-06	0.000127	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CD36—atherosclerosis	8.7e-06	0.000126	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SPP1—atherosclerosis	8.66e-06	0.000126	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	8.62e-06	0.000125	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	8.52e-06	0.000124	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—BGN—atherosclerosis	8.49e-06	0.000123	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	8.49e-06	0.000123	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MTHFR—atherosclerosis	8.42e-06	0.000122	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA5—atherosclerosis	8.4e-06	0.000122	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARA—atherosclerosis	8.26e-06	0.00012	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MTHFR—atherosclerosis	8.24e-06	0.00012	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARA—atherosclerosis	8.09e-06	0.000117	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	8.09e-06	0.000117	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PDGFB—atherosclerosis	8.01e-06	0.000116	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AGT—atherosclerosis	8e-06	0.000116	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	7.89e-06	0.000114	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOE—atherosclerosis	7.84e-06	0.000114	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AGT—atherosclerosis	7.83e-06	0.000114	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AGT—atherosclerosis	7.82e-06	0.000113	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.81e-06	0.000113	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CAV1—atherosclerosis	7.76e-06	0.000113	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APOA1—atherosclerosis	7.75e-06	0.000112	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AGT—atherosclerosis	7.7e-06	0.000112	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOE—atherosclerosis	7.68e-06	0.000111	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LEP—atherosclerosis	7.67e-06	0.000111	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOE—atherosclerosis	7.67e-06	0.000111	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CAV1—atherosclerosis	7.61e-06	0.00011	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CAV1—atherosclerosis	7.6e-06	0.00011	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APOA1—atherosclerosis	7.59e-06	0.00011	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APOA1—atherosclerosis	7.58e-06	0.00011	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LEP—atherosclerosis	7.54e-06	0.000109	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOE—atherosclerosis	7.54e-06	0.000109	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	7.47e-06	0.000108	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	7.46e-06	0.000108	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ESR1—atherosclerosis	7.32e-06	0.000106	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—F2—atherosclerosis	7.23e-06	0.000105	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	7.2e-06	0.000104	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—F2—atherosclerosis	7.11e-06	0.000103	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CG—atherosclerosis	7.07e-06	0.000103	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.01e-06	0.000102	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LIPC—atherosclerosis	6.96e-06	0.000101	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CG—atherosclerosis	6.93e-06	0.0001	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOC3—atherosclerosis	6.92e-06	0.0001	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	6.92e-06	0.0001	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LDLR—atherosclerosis	6.88e-06	9.97e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PPARG—atherosclerosis	6.83e-06	9.9e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	6.81e-06	9.87e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CETP—atherosclerosis	6.72e-06	9.74e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—INS—atherosclerosis	6.69e-06	9.71e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PPARG—atherosclerosis	6.69e-06	9.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	6.63e-06	9.61e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—INS—atherosclerosis	6.56e-06	9.51e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—INS—atherosclerosis	6.55e-06	9.5e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	6.52e-06	9.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—INS—atherosclerosis	6.44e-06	9.34e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCL2—atherosclerosis	6.44e-06	9.34e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.43e-06	9.33e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	6.34e-06	9.19e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—atherosclerosis	6.33e-06	9.18e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	6.23e-06	9.04e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALB—atherosclerosis	6.14e-06	8.9e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.07e-06	8.81e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	6.02e-06	8.72e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALB—atherosclerosis	6.01e-06	8.72e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	5.92e-06	8.58e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—NOS3—atherosclerosis	5.87e-06	8.51e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—NOS3—atherosclerosis	5.75e-06	8.34e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NOS3—atherosclerosis	5.74e-06	8.33e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	5.65e-06	8.19e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.41e-06	7.85e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—atherosclerosis	5.37e-06	7.79e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—atherosclerosis	5.26e-06	7.63e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	5.09e-06	7.39e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	5.01e-06	7.27e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	4.92e-06	7.14e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—atherosclerosis	4.84e-06	7.02e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	4.84e-06	7.02e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	4.77e-06	6.91e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.65e-06	6.74e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MMP9—atherosclerosis	4.61e-06	6.68e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	4.56e-06	6.61e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	4.53e-06	6.57e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	4.49e-06	6.5e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	4.48e-06	6.5e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	4.47e-06	6.48e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOB—atherosclerosis	4.45e-06	6.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	4.41e-06	6.39e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	4.4e-06	6.38e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.33e-06	6.28e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LPL—atherosclerosis	4.25e-06	6.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX1—atherosclerosis	4.14e-06	6.01e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	4.14e-06	6e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—STAT3—atherosclerosis	4.1e-06	5.94e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	4.07e-06	5.9e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CD36—atherosclerosis	4.04e-06	5.85e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	4.03e-06	5.85e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	3.91e-06	5.68e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	3.85e-06	5.58e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.83e-06	5.55e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	3.8e-06	5.51e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARA—atherosclerosis	3.75e-06	5.44e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	3.74e-06	5.42e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AGT—atherosclerosis	3.63e-06	5.27e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOE—atherosclerosis	3.56e-06	5.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CAV1—atherosclerosis	3.53e-06	5.12e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APOA1—atherosclerosis	3.52e-06	5.1e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.21e-06	4.66e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.1e-06	4.5e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—INS—atherosclerosis	3.04e-06	4.41e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—atherosclerosis	2.86e-06	4.15e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.82e-06	4.08e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALB—atherosclerosis	2.79e-06	4.04e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—AKT1—atherosclerosis	2.7e-06	3.91e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.67e-06	3.87e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—AKT1—atherosclerosis	2.64e-06	3.83e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKT1—atherosclerosis	2.64e-06	3.83e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	2.6e-06	3.77e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.44e-06	3.54e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.23e-06	1.78e-05	CbGpPWpGaD
